Earnings Recap – November 2nd
Pfizer smashed third-quarter earnings expectations. The company reported adjusted earnings per share of $1.34 vs. analysts’ expectations of $1.08. Pfizer’s revenue more than doubled to $24.09 billion from vs analysts’ $22.57 billion. In addition, vaccine revenue increased to $14.6 billion from $1.7 billion. The company expects COVID vaccine sales for the year of about $36 billion.
American Water reported Q3 earnings results in line with Wall Street expectations. The company reported earnings of $1.53 per share vs. $1.46 per share in the year-ago period. Analysts were expecting the company to earn $1.53 per share. Revenue rose 0.9% to $1.09 billion.
I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.